Recurrent pericarditis due to natalizumab treatment.
Service de Neurologie, 30 voie Romaine, 06002 Nice, Cedex, France.
Mikael
M
Cohen
Fanny
F
Rocher
Claude
C
Brunschwig
Christine
C
Lebrun
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001241:Aspirin / Q000627:therapeutic use; D002637:Chest Pain / Q000209:etiology; D003078:Colchicine / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D004452:Echocardiography; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D007155:Immunologic Factors / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D010493:Pericarditis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D010496:Pericardium / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D013610:Tachycardia / Q000209:etiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006633:Histamine Antagonists; D007155:Immunologic Factors; D000069442:Natalizumab; D001241:Aspirin; D003078:Colchicine; D011241:Prednisone